| Name | Title | Contact Details |
|---|
Generamedix Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Basking Ridge, NJ. To find more information about Generamedix Inc., please visit www.generamedix.com
BIO 101 is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wisconsin Women'S Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ChartSpan is a healthcare data company serving patients, providers and employers. Consumers use ChartSpan`s Patient Platform to manage their electronic healthcare records and information on their smartphone, tablet or computer. ChartSpan`s iPhone, iPad, Android and Android Tablet apps have all become the #1 most downloaded medical apps in the U.S. Providers (hospitals, clinics and doctors) leverage ChartSpan`s consumer products to deliver world-class patient EaaS (Engagement-as-a-Service™) to their patients. Employers utilize ChartSpan`s consumer products to manage wellness and healthcare analytics within its employee population.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.